von Moltke Lisa — SEC Form 4 filings
SEC reporting owner CIK 1808592. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 16,039 shares, $13,551 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 4,400 shares @ $1.08 ($4,752) in Seres Therapeutics, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | See Remarks | 7 | — | 6 legs · 16,039 sh · $13,551 | 18 |
| Cara Therapeutics, Inc. (CARA) | Director | 1 | — | — | 2 |
| Zenas BioPharma, Inc. (ZBIO) | See Remarks | 2 | — | — | 2 |
Form 4 filings — von Moltke Lisa
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,969 · Option exercise (M): 8,907 · Sale (S): 4,416 @ $0.81 · Option exercise (M): 2,969 (derivative) @ $0 · Option exercise (M): 8,907 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,969 · Sale (S): 977 @ $0.54 · Option exercise (M): 2,969 (derivative) @ $0 | EDGAR |
| 2024-10-29 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 13,744 @ $0 · Sale (S): 4,334 @ $0.69 · Option exercise (M): 13,744 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,969 · Sale (S): 973 @ $0.84 · Option exercise (M): 2,969 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 150,647 @ $0 · Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 2,968 · Sale (S): 939 @ $0.94 · Option exercise (M): 2,968 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 11,875 · Sale (S): 4,400 @ $1.08 · Grant/award (A): 213,750 (derivative) @ $0 · Grant/award (A): 287,905 (derivative) @ $0 · Grant/award (A): 35,625 (derivative) @ $0 · Option exercise (M): 11,875 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808592 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →